scholarly journals Regenerative Medicine: A New Paradigm in Bone Regeneration

Author(s):  
Orlando Chaparro ◽  
Itali Linero

The researchers across the world are actively engaged in strategic development of new porous aerogel materials for possible application of these extraordinary materials in the biomedical field. Due to their excellent porosity and established biocompatibility, aerogels are now emerging as viable solutions for drug delivery and other biomedical applications. This chapter aims to cover the diverse aerogel materials used across the globe for different biomedical applications including drug delivery, implantable devices, regenerative medicine encompassing tissue engineering and bone regeneration, and biosensing.


2019 ◽  
Vol 46 ◽  
pp. 1-9 ◽  
Author(s):  
Praveen Kumar L. ◽  
Sangeetha Kandoi ◽  
Ranjita Misra ◽  
Vijayalakshmi S. ◽  
Rajagopal K. ◽  
...  

Nanoscale ◽  
2019 ◽  
Vol 11 (37) ◽  
pp. 17230-17234
Author(s):  
Aijun Li ◽  
Yu Fan ◽  
Xueyan Cao ◽  
Liang Chen ◽  
Le Wang ◽  
...  

Morpholino-functionalized phosphorus dendrimers strongly promote the transformation of mesenchymal stem cells into osteoblasts for potential applications in bone regeneration.


2015 ◽  
Vol 8 (6) ◽  
pp. 98
Author(s):  
D. Cherepakhin ◽  
Yu. Belov ◽  
P. Shved ◽  
Yu. Bukina ◽  
A. Lichtenberg ◽  
...  

2018 ◽  
Vol 6 (1) ◽  
pp. 60-78 ◽  
Author(s):  
I. M. Bjørge ◽  
S. Y. Kim ◽  
J. F. Mano ◽  
B. Kalionis ◽  
W. Chrzanowski

Extracellular vesicles are highly specialized messengers that deliver vital biological signals including ribonucleic acids – key modulators in tissue regeneration.


2010 ◽  
Vol 5 (2) ◽  
pp. 279-288 ◽  
Author(s):  
Hutan Ashrafian ◽  
Ara Darzi ◽  
Thanos Athanasiou

Biomaterials ◽  
2010 ◽  
Vol 31 (13) ◽  
pp. 3552-3563 ◽  
Author(s):  
Sheeny K. Lan Levengood ◽  
Samantha J. Polak ◽  
Matthew B. Wheeler ◽  
Aaron J. Maki ◽  
Sherrie G. Clark ◽  
...  

Toukeibu Gan ◽  
2007 ◽  
Vol 33 (3) ◽  
pp. 238-243
Author(s):  
Hideaki Kagami ◽  
Izumi Asahina ◽  
Hideki Agata ◽  
Yuji Narita ◽  
Noriyuki Yamamoto ◽  
...  

2020 ◽  
Vol 6 (24) ◽  
pp. eaba7602
Author(s):  
Ziad Julier ◽  
Rezvan Karami ◽  
Bhavana Nayer ◽  
Yen-Zhen Lu ◽  
Anthony J. Park ◽  
...  

Although growth factors (GFs) are key molecules for regenerative medicine, their use has been limited by issues associated with suboptimal delivery systems and incomplete understanding of their signaling dynamics. Here, we explored how proinflammatory signals affect GF regenerative potential. Using bone regeneration in mouse, we found that the regenerative capacity of two clinically relevant GFs (BMP-2 and PDGF-BB) is impaired by interleukin-1 receptor (IL-1R1). Mechanistically, IL-1R1 activation in bone-forming cells desensitizes them to GFs and accelerates senescence. Moreover, administration of the GFs triggers IL-1 release by macrophages. To provide localized and sustained IL-1R1 inhibition, we engineered IL-1R antagonist (IL-1Ra) to bind the extracellular matrix (ECM) very strongly and demonstrate that codelivering GFs with ECM-binding IL-1Ra induces superior regeneration. Thus, we highlight that GF regenerative activity is hindered by proinflammatory signals, and GF-based therapies should integrate immunomodulation. Particularly, ECM-binding IL-1Ra holds clinical translational potential by enhancing efficacy of GF therapies.


Sign in / Sign up

Export Citation Format

Share Document